Cargando…
Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro
BACKGROUND: Triple negative breast cancer (TNBC) is a molecular subtype of breast cancer, which is a major health burden of females worldwide. Thymoquinone (TQ), a natural compound, has been found to be effective against TNBC cells, and this study identified IL17RD as a novel target of TQ in TNBC ce...
Autores principales: | Khan, Md. Asaduzzaman, Zheng, Meiling, Fu, Jiewen, Tania, Mousumi, Li, Jun, Fu, Junjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238053/ https://www.ncbi.nlm.nih.gov/pubmed/35761256 http://dx.doi.org/10.1186/s12885-022-09782-z |
Ejemplares similares
-
Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
por: Asaduzzaman Khan, Md., et al.
Publicado: (2017) -
Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition
por: Khan, Md. Asaduzzaman, et al.
Publicado: (2015) -
Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1
por: Wei, Chunli, et al.
Publicado: (2022) -
Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics
por: Tania, Mousumi, et al.
Publicado: (2021) -
RNA-Sequencing Reveals Heat Shock 70-kDa Protein 6 (HSPA6) as a Novel Thymoquinone-Upregulated Gene That Inhibits Growth, Migration, and Invasion of Triple-Negative Breast Cancer Cells
por: Shen, Shiyi, et al.
Publicado: (2021)